ALTAMIR_REGISTRATION_DOCUMENT_2017

1

PRESENTATION OF THE COMPANY AND ITS ACTIVITIES

Presentation of the Company

1.2.3 PORTFOLIO

At 31 December 2017

Percentage interest in the underlying

Year of investment

operating company

Residual cost in €K

Stage of development

TMT (Technology – Media – Telecom) Marlink (1a) (2)

2016 2016 2016 2016 2008 2011 2017 2007 2017 2017 2016 2015 2016 2015 2015 2013

27.20% 20.90% 28.70% 35.17% 3.53% 17.10% 2.26% 2.54%

59,004 38,876 33,871 22,361 18,703 10,677 9,244 4,340 3,236 2,554 2,337 2,335

LBO LBO LBO LBO

InfoVista (1a) (2)

Melita (1a)

Nowo/Oni (1a)

Altran Technologies* (3)

Growth capital

Vocalcom (1a)

13,594 Growth capital

ThoughtWorks (1b) (2) Gfi Informatique* (3)

LBO LBO LBO LBO LBO LBO LBO LBO LBO LBO

ECi Software Solutions (1b)

1.41% 1.70% 0.49% 0.96% 0.57% 0.50% 0.22% 0.51%

Attenti (1b)

Engineering Ingegneria Informatica (1b)

Exact Software (1b)

Duck Creek Technologies (1b)

EVRY* (1b) Zensar* (1b)

1,173 1,126

GlobalLogic (1b)

624

224,055

HEALTHCARE Amplitude Surgical* (1a)

2011 2017 2017 2013 2016 2017 2016 2014 2015

13.42% 1.03% 1.62% 0.33% 0.90% 1.42% 0.48% 0.33% 0.63%

14,041 9,646 5,345 3,619 2,874 2,841 2,077

LBO LBO LBO LBO LBO LBO LBO LBO LBO

Unilabs (1b)

Syneron Candela (1b)

One Call Care Management (1b)

NuPharm365 (1b) (formerly Invent Neurax)

Kepro (1b)

Vyaire Medical (1b)

Genex (1b)

321 151

Ideal Protein (1b)

40,914

(1) Investments via the Apax funds. (1a) via the Apax France VIII and Apax France IX funds. (1b) via the Apax VIII LP and Apax IX LP funds. (2) Co-investments (alongside the Apax France VIII, Apax France IX and Apax IX LP funds). (3) Direct investments (legacy portfolio). * Listed company.

22 REGISTRATION DOCUMENT

• ALTAMIR 2017

www.altamir.fr